Beijing Shihong Pharmaceutical Research Center

Beijing Shihong Pharmaceutical Research Center is a specialized pharmaceutical research and development institution based in Beijing, China. Established in 2001, the center focuses on the development of small molecule drugs, particularly in the fields of hepatology, gastroenterology, and anti-infectives. It is well-known for its expertise in the synthesis and formulation of complex generic drugs and has been instrumental in bringing several key treatments to the Chinese market. Notable products developed by the center include Adefovir Dipivoxil and Entecavir for the treatment of chronic hepatitis B. The organization operates primarily as a research hub, providing technology transfer and R&D services to major domestic pharmaceutical companies.